Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 969,200 | 3,593,200 | 2,764,500 | 1,745,000 | 820,200 |
| Depreciation Amortization | 149,700 | 600,400 | 444,100 | 292,500 | 147,900 |
| Income taxes - deferred | 8,900 | -145,600 | -185,800 | -90,600 | 16,700 |
| Accounts receivable | -160,000 | 29,000 | -63,600 | -38,900 | -128,300 |
| Other Working Capital | -145,400 | -450,400 | -510,200 | -254,500 | -271,000 |
| Other Operating Activity | 193,400 | 292,800 | 226,700 | 126,800 | 147,500 |
| Operating Cash Flow | $1,015,800 | $3,919,400 | $2,675,700 | $1,780,300 | $733,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -126,900 | -643,000 | -456,900 | -227,700 | -97,800 |
| Net Acquisitions | -300,000 | -1,048,800 | -748,800 | -448,800 | -448,800 |
| Purchase Of Investment | -1,914,400 | -6,864,900 | -4,870,100 | -2,045,000 | -323,000 |
| Sale Of Investment | 1,181,100 | 4,063,000 | 3,363,400 | 975,500 | 373,600 |
| Purchase Sale Intangibles | -28,600 | -15,400 | -6,300 | N/A | N/A |
| Other Investing Activity | -43,000 | -59,900 | -33,700 | -10,100 | -6,800 |
| Investing Cash Flow | $-1,203,200 | $-4,553,600 | $-2,746,100 | $-1,756,100 | $-502,800 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 5,930,500 | 5,930,900 | N/A | N/A |
| Debt Repayment | N/A | -2,100 | -2,100 | N/A | N/A |
| Common Stock Issued | N/A | -70,900 | 45,500 | 34,700 | 25,600 |
| Common Stock Repurchased | 0 | -5,000,000 | -2,998,200 | -42,200 | N/A |
| Other Financing Activity | -5,000 | -74,400 | 8,700 | 84,700 | 55,200 |
| Financing Cash Flow | $-5,000 | $783,100 | $2,984,800 | $77,200 | $80,800 |
| Exchange Rate Effect | 15,100 | -45,800 | -30,300 | -24,200 | -37,800 |
| Beginning Cash Position | 1,308,000 | 1,204,900 | 1,204,900 | 1,204,900 | 1,204,900 |
| End Cash Position | 1,130,700 | 1,308,000 | 4,089,000 | 1,282,100 | 1,478,100 |
| Net Cash Flow | $-177,300 | $103,100 | $2,884,100 | $77,200 | $273,200 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,015,800 | 3,919,400 | 2,675,700 | 1,780,300 | 733,000 |
| Capital Expenditure | -126,900 | -643,000 | -456,900 | -227,700 | -97,800 |
| Free Cash Flow | 888,900 | 3,276,400 | 2,218,800 | 1,552,600 | 635,200 |